Prior SGLT2 Inhibitor and Metformin Use and Risk of Long COVID in Type 2 Diabetes: A Nationwide Population-Based Cohort Study
Ngiam et al., Infectious Diseases and Therapy, doi:10.1007/s40121-026-01362-z
https://c19early.org/ngiam2.html